4th Quarter - Report
CAUTHEN FORBES & WILLIAMS for GENENTECH
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement [Medicare Prescription Drug Act of 2003]; Issues relating to Prescription Drug User Fee Act; issues related to comparative effectiveness and follow-on biologics, issues related to FDA repeal of Avastin.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
Copyright/Patent/Trademark CPT
Intellectual Property and Process Patent Issues; HR 1908, Patent Reform Act (all provisions).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.